From GlobeNewswire: 2024-05-30 08:00:00

The Global Blood Screening Market is set to double from USD 2.5 billion in 2023 to USD 5.1 billion by 2033, with a CAGR of 7.39%. Blood screening aims to detect infection markers to ensure the safety of blood units. Factors driving the market include growing awareness, increased donations, and prevalence of chronic diseases.

The reagents & kits segment dominates the market, fueled by rising consumption for blood screening due to affordability and portability. NAT technology leads in microbiological blood screening, with a focus on HIV, hepatitis B and C, and syphilis. Blood banks see the largest market share due to growing partnerships and donations.

North America leads the market with significant growth, driven by the prevalence of chronic conditions, well-developed healthcare systems, and increasing awareness of blood safety. Asia-Pacific is expected to grow rapidly due to investments in technology and heightened awareness about blood donation. Key players include Bio-Rad Laboratories, Thermo Fisher Scientific, Roche, and others.

Recent developments include Thermo Fisher Scientific’s launch of PCR kits in India. Segments include product types, technology, and end-users, with regional analysis covering North America, Europe, Asia Pacific, and more. Other related reports include research on electrical stimulators, AI in healthcare, chronic wound care, and epilepsy treatment drugs. Contact Spherical Insights & Consulting for market insights.



Read more at GlobeNewswire: Global Blood Screening Market Size To Exceed USD 5.1